Back to results
US 2008/0176845 A1Published application
Antagonists of A2B adenosine receptors for treatment of inflammatory bowel disease
AssigneesUniversity of Virginia Patent Foundation, Emory University
InventorsShanthi V. Sitaraman, Joel M. Linden, Guoquan Wang, Robert Douglas Thompson, Jayson M. Rieger
Life of this patent
Estimating the term…
Abstract
The present invention relates to method for treating inflammatory bowel disease that includes administration of an effective amount of an antagonist of A2B adenosine receptors (ARs).
Claims16
A method for treating inflammatory bowel disease, comprising:
- administering to a patient in need thereof a therapeutically effective amount of an A2B adenosine receptor antagonist.
Dependencies are inferred from the claim text.